Immunis, Inc., a clinical-stage biotechnology company, has successfully completed a Phase 1/2a clinical trial of IMM01-STEM, a novel multi-active...

Asimov, a synthetic biology company focused on therapeutic design and manufacturing, has entered into a licensing agreement with RevOpsis...

Steritas LLC, a company focused on improving care for patients treated with steroids, has partnered with global immunology company...

AgelessRx, a leading telehealth platform specializing in longevity, has expanded its services to include sleep health. Recognizing the crucial...

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka Pharmaceutical Co., Ltd. plan to submit a Biologics License Application...

New guidelines presented at the 2024 American College of Rheumatology (ACR) Convergence address the critical need for effective lupus...

Vir Biotechnology announced a positive opinion from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) regarding...

Incyte, a global biopharmaceutical company, has temporarily halted enrollment in its Phase 2 clinical trial evaluating MRGPRX2 (INCB000262) for...

Adicet Bio has initiated a Phase 1 clinical trial for ADI-270, a novel cancer therapy. This trial focuses on...

Silence Therapeutics recently unveiled end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, an siRNA therapy, in individuals...